Indirect comparison of two quantitative immunochemical faecal occult blood tests in a population with average colorectal cancer risk

Journal of Medical Screening

Volumn 18, Issue 2, 2011, Pages 76-81

  Guittet, L ^a   Bailly, L ^a   Bouvier, V ^a   Launoy, G ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COLORECTAL TUMOR; FEMALE; HUMAN; IMMUNOCHEMISTRY; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OCCULT BLOOD;

AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD;

EID: 80051881702     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1258/jms.2011.011012     Document Type: Article

References (13)

1. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review for colorectal cancer screening using fecal occult blood test (Hemoccult): An update. Am J Gastroenterol 2008;103:1541-9 (Pubitemid 351813919)
2. Van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90 (Pubitemid 351899018)
3. Van Rossum LG, van Rijn AF, Laheij RJ, et al. Cutoff determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009;101:1274-81
4. Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: Random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100: 1103-10
5. Guittet L, Bouvier V, Mariotte N, et al. Performances of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples. Int J Cancer 2009;125:1127-33
6. Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002;9:99-103 (Pubitemid 35205230)
7. Grazzini G, Visioli CB, Zorzi M, et al. Immunochemical faecal occult blood test : Number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009;100:259-65
8. Launoy GD, Bertrand HJ, Berchi C, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005;115:493-6 (Pubitemid 40663756)
9. Park DI, Ryu S, Kim YH, et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010;105:2017-25
10. Imperiale TF, Glowinski EA, Juliar BE, Azzouz F, Ransohoff DF. Variation in polyp detection rates at screening colonoscopy. Gastrointest Endosc 2009;69:1288-95
11. Komuta K, Batts K, Jessurum J, et al. Interobserver variability in the pathological assessment of malignant colorectal polyps. Br J Surg 2004;91:1479-84 (Pubitemid 39518086)
12. Goulard H, Boussac-Zarebska M, Salines E, Bloch J. [French colorectal cancer screening pilot programme: updating in 2007.] InVS April 2009. http://www.invs.sante.fr/publications/2009/plaq-eval-depistage-cancer-colon/ plaq-eval-depistage-cancer-colon.pdf
13. Guittet L, Guillaume E, Levillain R, et al. Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 2011 May 16. DOI: 10.1158/1055-9965.epi-10-0594